Leemadeline (Talk | contribs) |
|||
Line 2: | Line 2: | ||
<html> | <html> | ||
− | < | + | <style> |
+ | * { | ||
+ | font-family:"Trebuchet MS"; | ||
+ | } | ||
+ | </style> | ||
+ | |||
+ | <p style="font-size:4vw; text-align:center"> Composite Parts </p> | ||
<p> Two of our composite parts contain Lac-inducible forms of our resistance genes. One is a reporter using the Blue Chromoprotein that we used as a control. The last is an antibiotic resistance gene that we improved by optimizing for <i>E. Coli</i></p> | <p> Two of our composite parts contain Lac-inducible forms of our resistance genes. One is a reporter using the Blue Chromoprotein that we used as a control. The last is an antibiotic resistance gene that we improved by optimizing for <i>E. Coli</i></p> |
Latest revision as of 01:51, 2 November 2017
Composite Parts
Two of our composite parts contain Lac-inducible forms of our resistance genes. One is a reporter using the Blue Chromoprotein that we used as a control. The last is an antibiotic resistance gene that we improved by optimizing for E. Coli
Part Name | Part Number | Part Function |
---|---|---|
uvsE Full Gene | BBa_K2195008 | Synthesized gene of Lac Promoter, RBS and uvsE |
Dsup Full Gene | BBa_K2195005 | Synthesized gene of Lac Promoter, RBS and Dsup |
Blue Chromoprotein Reporter | BBa_K2195007 | Synthesized gene of Lac Promoter, RBS and BCP |
Neomycin Phosphotransferase full gene | BBa_K2195002 | Confers antibiotic resistance to Kanamycin and Neomycin |